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Introduction
Podosomes are dynamic actin-rich adhesion structures that have
been identified in highly motile and invasive cells, such as
macrophages, osteoclasts, dendritic cells and transformed fibroblasts
(Marchisio et al., 1984; Tarone et al., 1985; Linder et al., 1999;
Burns et al., 2001). Podosome formation can also be induced by
phorbol ester (PE) treatment in other cell types, such as vascular
smooth muscle and endothelial cells (Fultz et al., 2000; Moreau et
al., 2003). Morphologically podosomes display an F-actin-rich core
that is surrounded by a ring structure containing integrins and
integrin-associated proteins. The integrins are distributed in an
isotype-specific manner with β1 integrin localizing to the core and
β2 integrin and β3 integrin localizing to the ring structure (Linder
and Aepfelbacher, 2003). A variety of other molecules have been
detected in podosomes, including cytoskeleton-associated proteins,
Tyr kinases, Ser/Thr kinases, integrins and RhoGTPases. With the
identification of podosome-associated proteins much progress has
been made on determining mechanisms responsible for podosome
formation. One of the first observations that had been established
was that the integrity of microtubules and the actin cytoskeleton is
crucial for podosome formation, because microtubule-
depolymerization by nocodazole treatment and F-actin-disassembly
with cytochalasin D both lead to a loss of podosomes (Lehto et al.,
1982; Linder et al., 2000). Further, F-actin in the podosome core
has a high turnover rate (Destaing et al., 2003), indicating continuous
actin polymerization that involves cortactin, Wiskott-Aldrich
syndrome protein (WASP) and Arp2/3. In fact, blocking the
functions of cortactin, N-WASP and the Arp2/3 complex using
dominant-negative mutants and RNA interference inhibits
podosome formation (Linder et al., 1999; Mizutani et al., 2002;
Kaverina et al., 2003; Tehrani et al., 2006; Webb et al., 2006). In
vivo, macrophages from Wiscott-Aldrich-syndrome patients, who
express a mutated WASP protein, are unable to assemble podosomes
(Linder et al., 1999). The importance of not only regulating actin
polymerization but also depolymerization in the podosome core is
evident by the influence of gelsolin, an actin-severing protein that
is indispensable for podosome assembly in osteoclasts (Chellaiah
et al., 2000). Consistently, overexpression of the gelsolin antagonist
caldesmon, which stabilizes actin filaments against actin-severing
proteins, also abolishes podosome formation (Eves et al., 2006;
Morita et al., 2007). In addition, Erk-dependent phosphorylation of
caldesmon is known to weaken its interaction with actin (Foster et
al., 2004) and makes F-actin accessible to severing-proteins such
as gelsolin. Therefore, polymerization and depolymerization of F-
actin and its associated proteins appear to have a crucial role in
podosome dynamics. Hence, modifications to actin-associated
proteins that alter their actin-binding and actin-organization
properties are important mechanisms of podosome regulation.
AFAP-110 is an actin-binding and -crosslinking protein that is
enriched in Src and phorbol ester (PE)-induced podosomes. In
vascular smooth muscle cells endogenous AFAP-110 localized
to actin stress fibers and, in response to treatment with phorbol-
12,13-dibutyrate (PDBu), to actin-rich podosomes. Since PEs
can activate PKCα, AFAP-110 is a substrate of PKCα and
PKCα–AFAP-110 interactions direct podosome formation, we
sought to identify a PE-induced phosphorylation site in AFAP-
110 and determine whether phosphorylation is linked to the
formation of podosomes. Mutational analysis revealed Ser277
of AFAP-110 to be phosphorylated in PE-treated cells. The use
of a newly generated, phospho-specific antibody directed against
phosphorylated Ser277 revealed that PKCα activation is
associated with PE-induced AFAP-110 phosphorylation. In
PDBu-treated A7r5 rat vascular smooth muscle cells,
immunolabeling using the phospho-specific antibody showed
that phospho-AFAP-110 is primarily associated with actin in
podosomes. Although mutation of Ser at position 277 to Ala
(AFAP-110S277A) did not alter the ability of AFAP-110 to localize
to podosomes, overexpression of AFAP-110S277A in treated and
untreated A7r5 cells resulted in an increased number of cells
that display podosomes. Video microscopy demonstrated that
AFAP-110S277A expression correlates with an increased number
of long-lived podosomes. Therefore, we hypothesize that AFAP-
110 phosphorylation and/or dephosphorylation is involved in
the regulation of podosome stability and lifespan.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/121/14/2394/DC1
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However, it is noteworthy that F-actin is also crosslinked within
podosomes, and less is known regarding the role of actin-filament-
crosslinking proteins in podosome formation.
Actin filament-associated protein 1 (AFAP1; also known and
hereafter referred to as actin-filament-associated protein of 110 kDa,
AFAP-110) belongs to the functional group of actin-binding proteins
that regulate actin-filament crosslinking through its ability to
undergo dynamic changes in multimerization (Qian et al., 2004).
AFAP-110 is composed of a functional actin-binding domain (Qian
et al., 2000) and several protein-binding motifs, including two SH2
(Guappone et al., 1998) and one SH3 (Guappone and Flynn, 1997)
binding motifs, two pleckstrin homology (PH) domains and a
leucine-zipper (LZ) motif (Qian et al., 1998; Qian et al., 2004). In
quiescent cells AFAP-110 colocalizes to actin stress filaments (Flynn
et al., 1993). Upon knockdown of AFAP-110 using small hairpin
RNA (shRNA), actin stress filaments are lost, cell adhesion to
fibronectin is reduced 2.7 times and cells fail to form focal
adhesions (Dorfleutner et al., 2007). Therefore, the actin crosslinking
function of AFAP-110 is involved in the formation of actin stress
fibers, which is crucial for regulating cell contractility and cell
adhesion. The SH3-binding motif of AFAP-110 has been shown to
interact with the SH3 domains of the Tyr kinases Src, Fyn and Lyn.
This SH3 interaction is necessary and sufficient
to direct Src activation and results in
phosphorylation of AFAP-110 on Tyr residues
(Reynolds et al., 1989; Flynn et al., 1993; Baisden
et al., 2001a; Gatesman et al., 2004). Mutation of
the proline residue at position 71 to Ala (P71A)
within the SH3-binding motif abolishes Src
binding to AFAP-110 and prevents AFAP-110
from directing Src activation. The N-terminal PH
domain (PH1) was found to bind to the protein
kinase C (PKC) α, β, γ and λ isoforms and, upon
PKCα activation, AFAP-110 subsequently
becomes phosphorylated on Ser/Thr residues (Qian
et al., 2002; Qian et al., 2004). Phosphorylation
of AFAP-110 will induce a conformational change
that releases autoinhibitory intramolecular
interactions and correlates with an acquired ability
to activate Src, alter actin filament crosslinking and
induce podosome formation (Gatesman et al.,
2004). Thus, AFAP-110 might have an important
role in podosome formation as an actin-filament-
crosslinking protein and as an adaptor protein that
relays PKCα signals that direct Src activation.
As AFAP-110 is phosphorylated on Ser/Thr
residues in response to PKCα activation and PE
treatment, and phosphorylation of AFAP-110 on
Ser/Thr residues correlates with a change in
structure and function, we sought to identify a site
for Ser/Thr phosphorylation and evaluate its
specific role in AFAP-110 function. We
investigated whether PE-induced AFAP-110
phosphorylation occurs concomitant with
podosome formation in vascular smooth muscle
cells. PEs are well-known activators of classical
(α, β, γ) and novel (δ, ε, η and θ) PKC isoforms.
To date, PKCα and δ have been found to
participate in podosome regulation (Hai et al.,
2002; Tatin et al., 2006). Our data indicate
that PE-induced PKCα activation leads to
phosphorylation of Ser277 in AFAP-110. Mutation of Ser277 to
Ala did not affect localization to podosomes, but did result in an
increased number of cells with podosomes in A7r5 cells, which
correlated with an increase number of longer-lived podosomes.
Results
Endogenous AFAP-110 localizes to PE-induced podosomes in
A7r5 rat smooth muscle cells
To address localization of endogenous AFAP-110 in response to
PE stimulation and subsequent podosome formation, the rat aortic
smooth muscle cell line A7r5 was utilized, a well-characterized cell
system for podosome formation (Fultz et al., 2000; Brandt et al.,
2002; Hai et al., 2002; Burgstaller and Gimona, 2005; Eves et al.,
2006; Zhou et al., 2006). Immunofluorescence staining of uninduced
A7r5 smooth muscle cells displayed a well-formed actin
cytoskeleton, highlighted by prominent bundled actin stress fibers
(Fig. 1A, panel a). AFAP-110 has been previously described to
localize to actin stress fibers in fibroblasts, epithelial and endothelial
cells. In smooth muscle cells, AFAP-110 also localized to actin stress
fibers (Fig. 1A, panel b). Stimulation of A7r5 cells with the PE
phorbol-12,13-dibutyrate (PDBu), resulted in dissolution of stress
fibers and formation of actin-rich podosomes (Fig. 1A, arrows in
Fig. 1. (A) AFAP-110 localizes to PE-induced podosomes in A7r5 smooth muscle cells. A7r5
cells plated on fibronectin coated glass coverslips were either left untreated (a,b) or were treated
with 1 μM PDBu for 1 hour (c,d). Cells were stained with Rhodamine-labeled phalloidin to label
F-actin (a,c) and with a polyclonal AFAP-110 antibody (b,d). Confocal microscopy was used to
scan 0.7-μm-thick images along the ventral membrane of the cells to image the podosomes.
(B) GFP-AFAP-110 was transiently transfected into A7r5 cells and immunofluorescence images
were obtained using antibodies to detect endogenous vinculin (b) and cortactin (c), to contrast
with GFP fluorescence (a) in the merged image (d). (C) Monomeric dsRed-AFAP-110 was
transiently expressed in A7r5 cells that had been plated on an FITC-gelatin matrix containing
50 μg/ml fibronectin. 
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panel c). Consequently, endogenous AFAP-110
was found to colocalize to actin-rich podosomes
(Fig. 1A, arrows in panel d).
These structures were defined as podosomes
based on size, shape and localization to the ventral
membrane. In cells that ectopically express GFP-
AFAP-110, these structures also contained cortactin
(a molecular marker for podosomes) and a vinculin
ring, which is characteristic of podosomes (Fig. 1B,
panels a-d). Identification of these structures as
podosomes is also consistent with the observed
degradation of an FITC-gelatin matrix beneath these
structures (Fig. 1C, panels a-c). Thus, AFAP-110 is
associated with actin stress fibers and localizes to
PE-induced podosomes in A7r5 smooth muscle
cells, which is in agreement with the prediction of
previous studies (Qian et al., 2000; Gatesman et al.,
2004; Burgstaller and Gimona, 2004).
PE treatment causes a gel shift of the AFAP-
110 protein band
PEs are known to cause activation of classical and
novel members of the PKC family of Ser/Thr
kinases. AFAP-110 is a binding partner for PKCα,
a target of PKCα phosphorylation in vitro and
becomes phosphorylated on Ser residues upon PE
treatment in vivo (Qian et al., 2002). Here we show
that treatment of GFP-AFAP-110-overexpressing
cells treated with the PE phorbol-12-myristate-13-
acetate (PMA) resulted in a gel shift of the AFAP-
110 protein band in western blot analysis (Fig. 2A).
Gel shifts during SDS-PAGE can occur when a
protein is phosphorylated, which prevents SDS
from coating the protein efficiently, resulting in a
slightly retarded migration to the cathode and a
higher relative mass of the protein. Thus, because PMA is a well-
known activator of PKC family members such as PKCα (Kazanietz,
2000), and AFAP-110 is a substrate and binding partner for PKCα
(Qian et al., 2002), we predicted that the resulting gel shift was
associated with increased AFAP-110 phosphorylation on Ser/Thr
residue(s). Previous studies have found that phosphorylation of
AFAP-110 by recombinant PKCα can direct a conformational
change in AFAP-110 (Qian et al., 2004). Subsequently, we
determined that amino acids 270-300 are a major target region for
AFAP-110 phosphorylation in vitro (Lidia Cherezova and D.C.F.,
unpublished data). Sequence comparison of this region among
different species revealed highly conserved Ser residues that are
consistent with consensus PKC phosphorylation sites (Fig. 2B). To
identify the phosphorylated Ser residues, we created a mutant AFAP-
110 construct in which all relevant Ser residues (positions 277, 278,
282 and 283 according to the human AFAP-110 sequence) were
changed to Ala (hereafter referred to 4A mutant). No gel shift of
the A4 mutant protein (isolated from 4A-transfected cells stimulated
with PMA) was apparent when compared with AFAP-110 wild-
type (Fig. 2C, lanes 1 and 2), which indicated that at least one of
the four Ser residues is a potential phosphorylation target. To further
characterize the exact phosphorylation site, double mutants of
Ser277-Ser278 and Ser282-Ser283 to Ala277-Ala278 and Ala282-
Ala283, respectively, were generated and the mutant proteins were
tested for the phosphorylation-dependent gel shift after treating the
transfected cells with PMA. Fig. 2C shows that the S277A-S278A
Journal of Cell Science 121 (14)
mutant of AFAP-110 did not result in a gel shift (Fig. 2C, lanes 5
and 6) of the protein band in western blotting, whereas the S282A-
S283A mutant protein (Fig. 2C, lanes 7 and 8) still shifted similarly
to wild-type AFAP-110 after PMA treatment of transfected cells
(lanes 3 and 4). Therefore, the gel shift was attributed to
phosphorylation of Ser277 and/or Ser278. Single Ser substitution
of these residues revealed that the Ser277Ala mutation prevents the
AFAP-110 band gel shift in western blots subsequent to PMA
treatment of cells (Fig. 2D, lanes 1 and 2). In addition, we found
that pretreatment of cells with the PKC inhibitor
bisindolylmaleimide I (GF109203X; Fig. 2D, lanes 5 and 6) will
prevent a gel shift of the AFAP-110 protein band after PMA
treatment of cells. Previously published observations have indicated
that AFAP-110 is phosphorylated on four distinct tryptic fragments
in response to treatment with PMA (Qian et al., 2002). Thus,
although our data indicate that the presence of Ser277 is required
for the gel shift and is a good candidate site for phosphorylation,
other sites for phosphorylation do exist in AFAP-110 that might
contribute to the gel shift as well. In summary, the observed PMA-
induced gel shift could be associated with phosphorylation of AFAP-
110 through activation of a PKC pathway and Ser277 is a possible
candidate phosphorylation site.
Generation and characterization of a phospho-specific antibody
To define the phosphorylation state of endogenous AFAP-110 and
to further study the regulation of AFAP-110 phosphorylation, a
Fig. 2. PE treatment causes a gel shift of the GFP-AFAP-110 protein band in western blot
analysis that is dependent upon Ser277. (A) Western blot analysis of GFP-AFAP-110 transfected
COS-7 cell lysates. 48 hours post transfection cells were either left untreated (–) or treated for 1
hour with 100 nM PMA (+), directly lysed in SDS sample buffer and subjected to SDS-PAGE
and subsequent western blotting with GFP antibody. PMA treatment causes a gel shift of the
GFP-AFAP-110 protein band. The horizontal line is shown to contrast the gel shift. (B) Protein
sequence alignment of the Ser/Thr rich region between different species. Conserved Ser residues
that represent putative PKC target sites – [R/K]XX[S/T] and [R/K]X[S/T] (Pearson and Kemp,
1991) – and are underlined and have subsequently been mutated to Ala. (C,D) Western blot
analysis of GFP-AFAP-110 phosphorylation mutants. (C) Ser277, Ser278, Ser282 and Ser283
(as indicated in 2B) were mutated to Ala to create the 4A mutant (lanes 1 and 2). For double
mutants Ser277 and Ser278 or Ser282 and Ser283 were mutated to Ala to create S277A-S278A
or S282A-S283A mutants (277A278A and 282A283A lanes 5,6 and 7,8, respectively). (D) For
single mutants, Ser277 or Ser278 were mutated to Ala to create S277A or S278A (277A or
278A, respectively). All constructs were transfected into COS-7 cells and 48 hours post
transfection treated as indicated with PMA for 1 hour, while inhibition of PKC was
accomplished using the PKC inhibitor GF109203X (GF) for 30 minutes. All blots were probed
with anti-GFP antibody and the gelshifted protein bands are indicated by an asterisk. Molecular
mass markers are indicated on the left. The horizontal line is shown to contrast the gel shift.
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phospho-specific antibody was raised against an 11-amino-acid
peptide starting at Leu273 of the human AFAP-110 sequence that
included phosphorylated Ser277. In a dot-blot assay non-
phosphorylated or phosphorylated peptides were spotted at different
concentrations on a nitrocellulose membrane and hybridized with
the generated antiserum. The pre-immune serum did not contain
antibodies directed against the non-phosphorylated or
phosphorylated peptide (Fig. 3A). However, antiserum generated
from immunization with the phosphorylated peptide (anti-pSer277)
contained antibodies that immunoreacted specifically with the
phosphorylated peptide in a dose dependent manner but not with
the non-phosphorylated peptide.
To determine whether the gel shift shown in Fig. 2 correlated
with AFAP-110 phosphorylation on Ser277, a western blot was
performed using the anti-pSer277 antibody. Fig. 3B shows that PMA
treatment enabled the anti-pSer277 antibody to recognize AFAP-
110; however, this same antibody was unable to recognize GFP-
AFAP-110 that had Ser277 mutated to an Ala residue (AFAP-
110S277A). The western blot was stripped and reprobed with an
antibody against total AFAP-110, which demonstrated equal protein
expression levels (Fig. 3B, bottom panel). These data indicate that
PMA treatment enables anti-pSer277 antibodies to become
immunoreactive with AFAP-110. Thus, we hypothesize that Ser277
is a site for PMA-directed phosphorylation.
To establish the time course of phosphorylation of Ser277, cells
were stimulated with PMA and then harvested at the indicated times
(Fig. 3C). The anti-pSer277 antibody was immunoreactive with
GFP-AFAP-110 subsequent to PMA treatment, and we observed
that immunoreactivity to phospho-GFP-AFAP-110 accumulated
gradually until maximum immunoreactivity was reached after 1 hour
of PMA treatment. At later time points immunoreactivity with anti-
pSer277 antibodies declined but was still detectable for up to 24
hours after PMA stimulation (Fig. 3C).
The sequence alignment between human, chicken, rat and mouse
AFAP-110 in Fig. 2B shows that Ser277 is conserved between
species; therefore, the cross-immunoreactivity of the anti-pSer277
antibody was tested. Fig. 3D shows immunoreactivity with anti-
pSer277 antibodies against AFAP-110 from cells overexpressing
human and avian AFAP-110, as well as endogenous AFAP-110
immunoprecipitated from in A7r5 rat vascular smooth muscle cells
and a human breast cancer cell line that has previously been
described to have high levels of AFAP-110 (Dorfleutner et al., 2007).
Collectively, these data indicate that avian, human and rodent AFAP-
110 become immunoreactive with the anti-pSer277 antibody after
PE treatment, and that the newly generated AFAP-110 phospho-
specific antibody is highly specific for Ser277-phosphorylated
AFAP-110.
The presence of the PH1-domain of AFAP-110 is required for
AFAP-110 phosphorylation
To characterize the domains important for phosphorylation of
Ser277 in AFAP-110 we used mutated AFAP-110 constructs as
shown in Fig. 4A. Mutation of Pro71 to Ala will prevent AFAP-
110 interaction with SH3 domain-containing binding partners, such
as Src (Guappone and Flynn, 1997) and AFAP-110P71A is unable
to activate Src in response to PE treatment (Gatesman et al., 2004).
Deletion of the first PH domain (ΔPH1) will prevent AFAP-110
interaction with PKCα, β, γ or λ isoforms (Qian et al., 2002).
Deletion of the C-terminal 114 amino acids (1-616 mutant) removes
the ability of AFAP-110 to bind to actin (Qian et al., 2000) and
deletion of the C-terminal 177 aa (GFP-AFAP-110 1-553 mutant)
removes the actin-binding domain as well as the LZ motif which
has been shown to be important for intra- and intermolecular
interactions of AFAP-110 through LZ-LZ-domain or LZ-PH1-
Fig. 3. Characterization of the anti-pSer277 antibody as a potential phospho-
specific AFAP-110 antibody. (A) Specificity of the newly generated phospho-
specific AFAP-110 antibody was determined by dot-blot assay as described in
Materials and Methods. NP, non-phosphorylated peptides; P, phosphorylated
peptides. (B) Western blot analysis with the newly generated phospho-specific
AFAP-110 antibody anti-pSer277. Samples were prepared as described in
Fig. 2A,C, where a gel shift of the AFAP-110 protein band was observed in
response to PMA treatment in western blot analysis. Here the western blot was
probed with anti-pSer277 phospho-specific AFAP-110 antibody (α(P) AFAP,
upper panel) or with an antibody against total AFAP-110 (αAFAP, lower
panel) to control for equal expression of AFAP-110. (C) Time course of PMA-
induced immunoreactivity with anti-pSer277 antibodies. GFP-AFAP-110
transfected COS-7 cells were treated with 100 nM PMA for the indicated time,
prior to lysis in sample buffer, separation by SDS-PAGE and subsequent
western blot analysis with anti-pSer277 (α(P) AFAP, upper panel). After
stripping the membrane it was re-probed with a GFP antibody (lower panel), to
control for equal loading. (D) Anti-pSer277 antibodies are immunoreactive
with AFAP-110 in cells treated with PMA/PDBu. Anti-pSer277 antibody
(α(P) AFAP, upper panel) recognizes PMA/PDBu-induced phosphorylation of
overexpressed avian and human AFAP-110 as well as of endogenous human
and rat AFAP-110 in western blot analysis. Overexpression of AFAP-110 was
performed in COS-7 cells that had been lysed directly after PMA treatment.
Endogenous AFAP-110 was immunoprecipitated after PMA treatment, as
indicated, and SDS-PAGE and western blot analysis was performed.
Membranes were probed with anti-pSer277 antibodies (α(P) AFAP, upper
panel) and with a anti-AFAP antibody (lower panel), to control for equal
loading. All western blots are labeled with molecular mass markers on the left.
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domain binding (Qian et al., 2004). Fig. 4B shows that, in response
to PMA treatment, SH3 interactions were not necessary for AFAP-
110 phosphorylation on Ser277; interestingly, actin-filament binding
and oligomerization were also unnecessary. However, if the N-
terminal PH1 domain was deleted, AFAP-110 was not
immunoreactive with anti-pSer277 after PMA treatment and, thus,
predicted not to be phosphorylated on Ser277 in response to PMA
treatment. We did note a slight gel shift of GFP-AFAP-110ΔPH1
(Fig. 4B, anti-GFP blot) after exposure to PMA. Thus, because
AFAP-110 is known to be phosphorylated on four tryptic fragments
in vivo upon exposure to PMA, it might be that another distinct
phosphorylation site has been phosphorylated, which led to this
slight shift. Nevertheless, this experiment indicates that the presence
of the PH1 domain is required for PMA-directed phosphorylation
of Ser277.
PKCα phosphorylates AFAP-110 on Ser277 in vivo
AFAP-110 is a substrate for Ser/Thr phosphorylation in response
to PKCα activation in vitro and in vivo, and the PH1 domain of
AFAP-110 can bind to four different PKC isoforms (α,β,γ,λ), but
not the other six isoforms of PKC (Qian et al., 2002). Of the four
PKC isoforms that bind to AFAP-110, only α, β and γ are directly
activated by PMA (Nishizyka, 1992). Furthermore, in the cells we
use, PKCα is expressed at highest levels and we do not detect
PKCγ, consistent with the fact that this isoform has been associated
with neuronal cells (Saito and Shirai, 2002). Thus, we predicted
that PKCα may be responsible for directing phosphorylation of
Ser277, either directly or through its ability to activate another
Journal of Cell Science 121 (14)
Ser/Thr kinase that in turn can phosphorylate AFAP-110 at this
residue.
To begin to understand which kinases might be required for
phosphorylation of Ser277 in response to PE stimulation, we used
the broad-spectrum inhibitor staurosporine (STS) for PKCα and
other Ser/Thr kinases. Cells were pretreated with STS before PMA
induction. Fig. 5A shows that STS inhibits AFAP-110
phosphorylation in a dose-dependent manner. AFAP-110 has also
been shown to interact with and become phosphorylated on Tyr
residues by Src Tyr kinase (Guappone and Flynn, 1997), which is
activated in a PKC-dependent manner in response to PE treatment
of cells (Bruce-Staskal and Bouton, 2001; Brandt et al., 2002). To
investigate whether Src activation is a prerequisite of Ser
phosphorylation or whether Ser phosphorylation was independent
of Src kinase activity and, hence, upstream of PMA-induced Src
activation, cells were pretreated with the Src inhibitor PP2 before
induction with PMA. PP2 was not able to block PMA-induced
phosphorylation of Ser277 (Fig. 5A), indicating Ser phosphorylation
of AFAP-110 is upstream of or independent of Src activation. This
confirms our results shown in Fig. 4B where mutation of the AFAP-
110-binding site for Src (which would prevent AFAP-110 from
activating Src in response to PMA stimulation) did not affect PMA-
induced AFAP-110 phosphorylation on Ser277. Thus, PE-directed
phosphorylation of AFAP-110 on Ser277 occurs upstream or
independently of Src activation.
PKC isoforms have an important role in PE-induced podosome
formation (Hai et al., 2002; Tatin et al., 2006) and, therefore, their
involvement in the Ser phosphorylation of AFAP-110 was tested.
Cells were pretreated with the inhibitors Safingol or rottlerin, which
can block some PKC family members, as well as other Ser/Thr
kinases (Davies et al., 2000). Fig. 5B shows that Safingol, which
blocks PKCα, was able to block PMA-induced AFAP-110
phosphorylation – unlike rottlerin, which does not inhibit PKCα
(Soltoff, 2007). Overexpression of a myristylated PKCα construct,
which serves as a dominant-active form of PKCα, was able to direct
phosphorylation of AFAP-110 on Ser277 (Fig. 5C). PMA treatment
caused an increase of AFAP-110 phosphorylation in cells expressing
myrPKCα, which may be due to activation of endogenous PKCα,
resulting in a substantial increase in AFAP-110 phosphorylation.
Lastly, treatment of cells with GF109203X, which has reasonably
good specificity for PKCα, resulted in a substantial reduction in
the phosphorylation of Ser277 (Fig. 5D). It is important to add that
these experiments were conducted in COS-7 cells, which contain
substantial levels of PKCα. COS-7 cells are also able to form
podosomes in response to PE treatment (supplementary material
Fig. S1). These data indicate that PKCα can directly phosphorylate
Ser277 in AFAP-110. 
Phosphorylated AFAP-110 localizes to podosomes
To determine where phosphorylated AFAP-110 is localized,
immunofluorescence staining was performed on A7r5 cells that
overexpress GFP-AFAP-110. Western blot analysis showed that
AFAP-110 was phosphorylated on Ser277 in A7r5 cells (Fig. 3D),
and these cells were therefore used for imaging. In untreated A7r5
cells GFP-AFAP-110 localized to actin stress fibers and this
localization is consistent with the location of endogenous AFAP-
110 (see Fig. 1). There was no signal using the anti-pSer277
antibody (Fig. 6, panels a-d) in unstimulated cells. After PDBu
treatment GFP-AFAP-110 and phospho-AFAP-110 localized
strongly to podosomes (Fig. 6, panels e-h). However, we were
unable to detect endogenous phospho-AFAP-110 using anti-pSer277
Fig. 4. The PH domain is required for phosphorylation of Ser277.
(A) Schematic of mutants used for the mapping of domains that are
indispensable for AFAP-110 phosphorylation on Ser277. P71, Pro71 of the
SH3-interaction domain; 71A, Pro71 to Ala mutation; PH, pleckstrin
homology; LZ, leucine zipper; ABD, actin-binding domain. (B) Western blot
analysis of AFAP-110 mutants described in Fig. 4A. 48 hours post transfection
cells were treated for 1 hour with 100 nM PMA as indicated, directly lysed in
sample buffer and SDS-PAGE and western blot analyses were performed.
Western blot results using anti-pSer277 antibody (α(P) AFAP; upper panel),
and anti-GFP antibody (lower panel) to control for equal loading. Molecular
mass markers on the left of the blots.
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with a good signal-noise ratio in response to PDBu. This might be
due to lower expression levels, and only a fraction of endogenous
AFAP-110 might be phosphorylated on Ser277, which would yield
phospho-AFAP-110 levels at or below detection limits. Therefore,
we conclude that GFP-AFAP-110 becomes phosphorylated on
Ser277 in A7r5 cells upon PDBu treatment and is localized to
podosomes.
Mutation of Ser277 to Ala leads to an increased number of
cells with podosomes
We sought to determine whether phosphorylation of Ser277 has a
role in PE-directed podosome formation. Upon GFP-AFAP-110
overexpression we noticed three different phenotypes based on
AFAP-110 colocalization with actin filaments in A7r5 cells (Fig.
7A). One phenotype displayed stress filaments only, referred to as
[A]; a second displayed a mix of stress filaments and podosomes
referred to as [A’]; and a third showed podosomes only and is
referred to as [A”]. The occurrence of these phenotypes was
quantified in Fig. 7B. In untreated cells the majority (76%) display
AFAP-110 colocalized with stress filaments, and cortactin localized
to the cytoplasm. In untreated cells, there was also a less prevalent
population of cells (21%) that had a mixture of stress fibers and
some small podosomes, indicating some capacity for these cells to
spontaneously produce podosomes. Only 3% of untreated cells
showed only podosomes with no evidence for well-formed stress
filaments. Spontaneous podosome formation in the absence of PDBu
may be associated with activation of endogenous PKC under the
culture conditions we use. Here, A7r5 cells were plated below
confluence levels, where the cells have an opportunity to migrate,
and it has been shown that migrating cells will exhibit activated
PKCα (Ng et al., 1999). Upon PDBu treatment, 45% of cells
expressing GFP-AFAP-110 showed stress filaments with no
evidence for podosome formation [A], 26% of the cells show a
mixture of stress fibers and podosomes [A’] and 29% display
Fig. 5. PKCα is involved in phosphorylation
of AFAP-110 on Ser277. (A,B) Kinase
inhibitors were added to GFP-AFAP-110
transfected COS-7 cells before PMA treatment
for 1 hour. Staurosporine (STS) to inhibit
Ser/Thr kinases and PP2 for Src kinase (A),
and Safingol (Saf) and rottlerin (Rot) to
selectively inhibit certain PKC isoforms as
well as other Ser/Thr kinases (B). Cell lysates
were separated by SDS-PAGE, and western
blotted with antibodies against anti-pSer277
(α(P) AFAP, upper panel), or anti-GFP (lower
panel) to control for equal loading. (C) PKCα
or the dominant-active myristoylated (myr-)
form of PKCα were co-expressed with GFP-
AFAP-110 in COS-7 cells and cells were
stimulated with 100 nM PMA for 1 hour as
indicated. Control cells were left untransfected
and also subjected to PMA treatment as
indicated. Cells were directly lysed in sample
buffer and subjected to SDS-PAGE and
western blot analysis using anti-pSer277
(α(P) AFAP; top panel), anti-GFP (α GFP;
middle panel) or anti-PKC (α PKC; bottom
panel). All blots are labeled with molecular
mass markers on the left. (D) Similarly, cells
expressing GFP-AFAP-110 were pre-treated
with GF109203X (GF), followed by stimulation with 100 nM PMA for 1 hour as indicated. Cells were directly lysed in sample buffer and subjected to SDS-PAGE
and western blot analysis using anti-pSer277 (α(P) AFAP, top panel) or anti-GFP (α GFP; bottom panel).
Fig. 6. Phosphorylated AFAP-110 localizes to
podosomes. A7r5 cells were transfected with
GFP-AFAP-110 constructs and either left
untreated (panels a-d) or treated with 1 μM
PDBu for 1 hour (panels e-h).
Immunofluorescence staining was performed as
described in Materials and Methods, with actin
pseudocolored in red, GFP-AFAP-110 in green
and the phosphorylation-specific AFAP-110
antibody anti-pSer277 (P-AFAP) in blue.
Merged pictures show colocalization of
phosphorylated AFAP-110 with AFAP-110 and
actin in podosomes.
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podosomes only [A”] (Fig. 7B). Podosomes were defined by their
size, shape, location and colocalization with cortactin, actin and
AFAP-110. Interestingly, A7r5 cells expressing AFAP-110S277A
showed more cells that formed podosomes (Fig. 7C). Cells
expressing the phosphorylation-defective AFAP-110S277A mutant
showed a greater propensity to express podosomes or a mix of
podosomes and stress filaments in the absence of PDBu treatment
(35% stress filaments, 33% mix, 32% podosomes only), whereas
PDBu treatment resulted in an increase in the number of cells that
express podosomes only (30% stress filaments, 15% mix, 55%
podosomes only) (Fig. 7B). These data indicate that GFP-AFAP-
Journal of Cell Science 121 (14)
110S277A expression correlated with an increased capacity for cells
to display podosomes.
Expression of AFAP-110S277A is associated with long-lived
podosomes
An increase in podosome numbers might be due to increased
production of podosomes or to a net decrease in the deconstruction
of podosomes (extended half-life). To investigate the effect of
AFAP-110S277A upon podosome lifespan, we performed time-lapse
video microscopy using A7r5 cells transiently expressing GFP-
AFAP 110 wild type (supplementary material Movie 1A) or GFP-
Fig. 7. GFP-AFAP-110S277A expression is
associated with an increased number of
cells that contain podosomes.
(A) Immunofluorescence staining of A7r5
cells, transfected with wild-type GFP-
AFAP-110 and treated with PDBu for 1
hour (A, A’, A”) to show cellular
morphologies demonstrating (A) stress
fibers, (A’) a mix of stress filaments and
podosomes or (A”) podosomes only.
(B) Quantification of GFP-AFAP-110-
expressing or GFP-AFAP-110S277A-
expressing A7r5 cells (uninduced and
PDBu-treated) that display stress fibers
(black), podosomes (white) or a mixed
population of stress fibers and podosomes
(checkerboard) correlating to A, A” or A’,
respectively. (C) GFP-AFAP-110S277A
expression (pseudocolored green) in A7r5
cells contrasted with TRITC-phalloidin
(pseudocolored red) and cortactin
detected with monoclonal antibody 4F11
(pseudocolored white). Cells were either
untreated or treated with PDBu for 60
minutes. Cells that expressed GFP-
AFAP-110S277A expressed either
predominantly podosomes or a mix of
stress filaments and podosomes.
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AFAP-110S277A mutant (supplementary material Movie 1B) and
monitored podosome dynamics in the absence of PDBu stimulation.
As shown in Fig. 8A, podosome lifespans were widely distributed
from less than 10 minutes to over 60 minutes. At least half of the
podosomes associated with wild-type GFP-AFAP-110 had lifespans
of <30 minutes and ~25% of podosomes had a lifespan of >60
minutes (Fig. 8A, gray bars) By contrast, the distribution of the
lifespans of podosomes associated with the GFP-AFAP-110S277A
mutation were shifted to longer time frames, with more than 50%
of podosomes in a given cell having lifetimes of greater than >60
minutes (Fig. 8A, black bars). To determine the average lifetime
of podosomes, a total of 361 podosomes from AFAP-110-
expressing cells and a total of 477 podosomes from AFAP-
110S277A-expressing cells were analyzed in three independent
experiments. Among those, only podosomes that appeared and
disappeared during the 2-hour video microscopy were used to
obtain average lifespan. As shown in Fig. 8B, expression of AFAP-
110S277A was associated with prolonged average lifespan of
podosomes, which averaged 28.6 minutes compared with 17.9
minutes of that in wild-type-expressing cells (P<0.0001, two-tailed
Student’s t-test, non equal variation). These data indicate that the
mutation of the Ser277 phosphorylation site to Ala is associated
with an increase in the number of long-lived podosomes and a
decrease of short-lived podosomes. Therefore, we conclude that
the enhanced number of podosomes observed in cells expressing
AFAP-110S277A results from an increased lifespan of these
podosomes.
Discussion
Podosomes are ventral-membrane-associated structures that
promote the release of proteases, which can degrade the extracellular
matrix and promote the ability of a cell to cross a tissue barrier
(Linder, 2007). In general, podosomes are associated with dendritic
cells, macrophages, osteoclasts, endothelial cells and smooth muscle
cells, whereas oncogene-transformed fibroblast cells will form
structures that resemble podosomes. A closely related cellular
structure, the invadopodium, will also promote the release of
proteases and the ability of a cell to cross a tissue barrier; however,
invadopodia are more commonly associated with carcinoma cells.
It is possible that podosomes and invadopodia are distinct structures
or related structures that form on the basis of specific interactions
with the substratum. Regardless, it is clear that these two structures
will form in response to activation of PKCα, and that the PKCα
substrate AFAP-110 is a component of these structures (Gatesman
et al., 2004; Burgstaller and Gimona, 2004; Dorfleutner et al., 2007).
Here, we show localization of endogenous AFAP-110 to podosomes
in the PDBu-treated vascular smooth muscle cell line A7r5, which
is widely used as a model system for podosome studies (Fultz et
al., 2000; Brandt et al., 2002; Hai et al., 2002; Burgstaller and
Gimona, 2005; Eves et al., 2006; Zhou et al., 2006). AFAP-110
consistently colocalized to podosomes and appears to be a reliable
molecular marker for podosomes, where cortactin and Tks5 together
with F-actin are the standard molecular biomarkers for defining
podosomes on the ventral membrane of cells (Gimona et al., 2008).
Our previous work has demonstrated that PKCα-directed Src
activation occurs in an AFAP-110 dependent fashion, and it was
this signaling cascade that was responsible for PKCα-directed
podosome formation (Gatesman et al., 2004; Walker et al., 2007).
Here, activated PKCα is able to bind to the PH1 domain of AFAP-
110 and direct Ser/Thr phosphorylation of AFAP-110 (Qian et al.,
2002), resulting in a conformational change in AFAP-110 structure
that both promoted its ability to crosslink actin filaments (Qian et
al., 2004) and enabled it to colocalize with and subsequently activate
Src (Walker et al., 2007). Thus, we predicted that phosphorylation
of AFAP-110 by PKCα may play an important role in modulating
its structure and function and this may be associated with podosome
formation. As AFAP-110 is phosphorylated on at least four tryptic
fragments in PE-treated cells (Qian et al., 2002), we predicted that
one or more of these phosphorylation sites might be relevant to its
function.
In this study, we sought to identify a specific site for
phosphorylation and assess whether phosphorylation of AFAP-110
may correlate with podosome formation. Preliminary in vitro
studies indicated that a major site for phosphorylation of AFAP-
110 by PKCα localized to amino acids 270-300 (Lidia Cherezova
and D.C.F., unpublished data). This sequence contained four Ser
and two Thr residues. We noticed that three of the four Ser residues
(Ser277, Ser278 and Ser282) were positioned two amino acids away
from positively charged Arg or Lys residues, which was defined as
optimal for phosphorylation by Arg-Lys directed Ser/Thr kinases,
such as PKCα (Pearson and Kemp, 1991). We noticed that, upon
PE stimulation, AFAP-110 gelshifts when carrying out a 8% SDS-
PAGE. Previously, we had found that AFAP-110 gelshifts in
response to Src activation (which can direct PKCα activation) and
that the gelshifted population was associated with a Triton-X-100-
insoluble fraction of cell lysates, indicating a tight association with
the cytoskeleton (Baisden et al., 2001b). Gelshifting is usually
associated with Ser/Thr phosphorylation and occurs when proteins
are phosphorylated on a site that is at or near the surface of a protein
Fig. 8. GFP-AFAP-110S277A expression increases the average lifespan of a
podosome. (A) Percentages of podosomes were plotted against their lifespan
in incremental 10-minute time brackets. The mean percentages of podosomes
observed in cells from three different experiments is given ± s.d. (B) The
average lifespan of podosomes was 17.9±17 minutes in cells that express
GFP-AFAP 110 wild type (gray bar) and 28.6±21 minutes in cells that
overexpress GFP-AFAP-110S277A (black bar); the difference is statistically
significant (P<0.0001).
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whose negatively charged phosphate residue prevents negatively
charged SDS from efficiently coating the protein, resulting in a
retarded migration to the cathode (less-negatively charged SDS
coating the protein) and an apparent increase in the molecular mass.
Thus, we used gelshifting as a guide to identify a potential
phosphorylation site. Mutation of Ser277 to Ala prevented AFAP-
110S277A from gelshifting in response to PE treatment. Thus, we
predicted Ser277 to be a phosphorylation site and obtained an
antibody that specifically recognizes AFAP-110 phosphorylated at
Ser277. This phospho-specific antibody (anti-pSer277) recognized
only one major protein band among proteins obtained from cell
lysates and separated by 8% SDS-PAGE and immunoreactivity was
specifically associated with phosphorylation of Ser277.
Immunoprecipitation of AFAP-110 and western blot analysis with
anti-pSer277 confirmed its specificity for AFAP-110 and, as
predicted by sequence analysis, it was crossreactive with the avian,
human and rodent homologs of AFAP-110. Thus, we conclude that
Ser277 is a site for phosphorylation in AFAP-110 in response to
PE stimulation.
Interestingly, phosphorylation of AFAP-110 in response to PE
treatment was dependent upon the presence of the PH1 domain.
Previous work by our lab demonstrated that the PH1 domain is a
site for binding by the PKC α, β, γ and λ isoforms (Qian et al.,
2002). Furthermore, AFAP-110 can relay signals from PKCα that
direct Src activation; however, deletion of the C-terminal half of
the PH1 domain prevented PKCα from directing Src activation.
Thus, we predict that PKCα binds to the PH1 domain of AFAP-
110 as a prelude to phosphorylating AFAP-110. It is interesting that
the N-terminal PH domain in the protein pleckstrin will also bind
to PKCα, and that phosphorylation of Ser113 and Ser117, which
like Ser277 occurs, are within 25 amino acids of, and proximal to,
the termination of their PH domains (Craig and Harley, 1996; Yao
et al., 1997). Thus, it might be possible that the binding of PKCα
to a PH domain orients it such it can phosphorylate a specific Ser/Thr
residue adjacent to the PH domain. The ability of PEs to stimulate
phosphorylation of AFAP-110 at Ser277 was not dependent upon
the ability of AFAP-110 to bind to Src. Pro71 is a key component
of the left-handed, type II poly-proline helix that engages the Src
SH3 domain (Guappone and Flynn, 1997). Binding to Src through
this motif will serve to activate Src (Baisden et al., 2001a). As Src
will in turn activate other Ser/Thr kinases (including PKCα), we
infer from these data that PE-directed phosphorylation of Ser277
occurs upstream and independent of Src activation. This is
confirmed with the addition of PP2, which failed to block AFAP-
110 phosphorylation on Ser277 in response to PE treatment. It seems
surprising that actin filament binding was not required for
phosphorylation of Ser277, indicating that strict positioning upon
the cytoskeleton was not a prerequisite for phosphorylation of
AFAP-110 in response to PE treatment.
PEs activate a variety of signaling proteins in addition to classical
and novel PKC family members (Kazanietz, 2000). Thus, it is
possible that a kinase other than PKC was directing phosphorylation
of AFAP-110 on Ser277. To begin to address this, we utilized broad-
spectrum inhibitors that have some specificity for PKC family
members, as well as other Ser/Thr kinases (Davies et al., 2000).
Staurosporine and Safingol have some specificity for PKCα as well
as other Ser/Thr kinases and were able to block PMA-directed
phosphorylation of Ser277. Rottlerin can block the activity of some
Ser/Thr kinases, but does is not specific for PKCα and was unable
to block phosphorylation of Ser277 in response to PE treatment. In
addition, expression of myrPKCα directed phosphorylation of
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Ser277, and GF109203X – which has reasonable specificity for
PKCα – blocked PE-directed phosphorylation of Ser277.
Collectively, these data are consistent with PKCα being responsible
for mediating phosphorylation of Ser277 in response to PE
treatment. Thus, we hypothesize that PE-directed activation of
PKCα directs it to bind to the PH1 domain of AFAP-110 and
phosphorylate it directly on Ser277.
We assessed the functional implications of phosphorylation of
Ser277. Anti-pSer277 localized phospho-AFAP-110 to podosomes,
although some immunoreactivity was apparent on stress filaments
in cells that showed a mix of podosomes and stress filaments, which
had formed in response to PE treatment (data not shown). Anti-
pSer277 was not able to efficiently detect endogenous phospho-
AFAP-110. This might be due to lower protein expression levels
(relative to transfected cells) and that only a fraction of the
endogenous proteins is phosphorylated, placing immunoreactivity
of endogenous phospho-AFAP-110 at or below detection limits. As
ectopically expressed GFP-AFAP-110 aligned with stress filaments
and podosomes in a fashion that is consistent with that of
endogenous protein, we assessed the role of GFP-AFAP-110S277A
in podosome formation relative to GFP-AFAP-110. It is noteworthy
that GFP-AFAP-110S277A localizes to podosomes as well as GFP-
AFAP-110. Thus, phosphorylation of AFAP-110 on Ser277 is not
required for podosome localization to occur. However, we noticed
that a substantial number of unstimulated A7r5 cells that expressed
GFP-AFAP-110S277A contained podosomes, whereas only a small
fraction of the unstimulated A7r5 cells that expressed GFP-AFAP-
110 had podosomes. Furthermore, upon stimulation with PDBu, a
greater proportion of A7r5 cells that expressed GFP-AFAP-110S277A
had podosomes relative to those cells that expressed GFP-AFAP-
110. We believe that the presence of podosomes in unstimulated
cells is linked to our cell culture conditions, because we plated and
observed the A7r5 cells at subconfluent concentrations. Under these
conditions, the cells can be motile and it has been shown that PKCα
will become activated during cell migration (Ng et al., 1999),
indicating a possible mechanism by which podosomes may form
in unstimulated cells. The number of podosomes associated with
GFP-AFAP-110S277A expression was substantially higher, indicating
either an increased rate of podosome formation or increased
podosome stability. Thus, we used video microscopy to analyze
podosome half-life. We showed that expression of AFAP-110S277A
leads not only to an increased number of total cells with podosomes
but also to an increase in the number of long-lived podosomes. Thus,
it is possible that phosphorylation of Ser277 is important for the
deconstruction of podosomes, and that loss of this phosphorylation
site results in podosomes with a longer half-life. Also possible is
that long-lived podosomes are different compared with short-lived
podosomes. We did notice a trend that indicated long-lived
podosomes were larger than short-lived podosomes, which is the
subject of an ongoing study in our lab (Y.C. and D.C.F.,
unpublished). In general, podosomes have a relatively short half-
life (~10 minutes or less). Interestingly, invadopodia have a half-
life of 2-3 hours and can be significantly larger than short-lived
podosomes (Linder, 2007). Thus, it is possible that phosphorylation
and dephosphorylation of AFAP-110 has a role in fostering dynamic
changes in size and longevity of podosomes.
We hypothesize that phosphorylation of AFAP-110 on Ser277
promotes deconstruction of podosomes and this may be relevant
for podosome half-life. There is a subset of proteins that are thought
to have a role in regulating podosome half-life, and that may be
important regulators of podosome structure and function. Recently
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it has been shown that inhibition of Erk1/2 phosphorylation leads
to increased podosome lifetime in PDBu-stimulated A7R5 cells (Gu
et al., 2007). Through detailed mathematical modeling, it has been
shown that increased podosome lifetime was mainly affected by
the decreased rate constant for podosome disassembly, which
indicated that Erk1/2 phosphorylation is involved in facilitating
podosome disassembly. In that regard, it is possible that
phosphorylation of Ser277 of AFAP-110, similar to Erk1/2
phosphorylation, is another physiologically relevant event that can
promote disassembly of podosomes. Another protein that could
regulate podosome half-life is cofilin, because knockdown of
cofilin results in decreased invadopodia half-life (Yamaguchi et al.,
2005). It has been speculated that this property of cofilin makes it
one of the master switches that promote transition of podosomes
to invadopodia (Linder, 2007). AFAP-110 might have similar
properties. Finally, it is also possible that AFAP-110, as a protein
that regulates cell contractility and crosslinks stress filaments,
regulates podosome half-life through these functions. Podosomes
are adhesive structures and their formation might be dependent upon
contractility. To this end, we have noticed the presence of myosin
II in the ring of podosomes associated with AFAP-110S277A, similar
to that observed by others in podosomes (Burgstaller and Gimona,
2004; van Helden et al., 2008), and reminiscent of the localization
pattern of vinculin (supplementary material Fig. S2). It is possible
that phosphorylation of AFAP-110 affects a change in actin filament
crosslinking, interactions with myosin II and contractility; however,
there is not an apparent change in myosin II localization around
podosomes that express AFAP-110S277A, compared with that
described in previous reports. It is noteworthy that, in vitro,
recombinant AFAP-110 exists as a multimer (it is predicted to be
a nonamer) and that in this form it is able to promote organizational
changes with actin filaments that have been predicted to exist in
meshworks. However, upon phosphorylation by PKCα, AFAP-110
assumes a smaller multimeric existence (possibly that of a trimer),
which is able to promote tight packing of stress filaments and has
been predicted to be an efficient F-actin-bundling protein (Qian et
al., 2004). Thus, phosphorylation of AFAP-110 and subsequent
dephosphorylation might affect changes in conformation that alter
stress filament crosslinking patterns, and this ability might promote
changes in actin filament architecture in response to contractility
changes. Studies are underway to determine the effect of Ser277
phosphorylation on the actin filament crosslinking properties of
AFAP-110. However, our hypothesis is that AFAP-110S277A is
unable to transition from an actin-meshworking to an actin-filament-
crosslinking protein and this inability might impede contractility
signals that promote deconstruction of podosomes in response to
changes in cellular signals or cell adhesion. Since AFAP-110 is
positioned at specialized microdomains at the interface between
focal adhesion and stress fiber – the origin of podosome formation
(Burgstaller and Gimona, 2004) – AFAP-110 would seem to be
well positioned to have a role in podosome formation. We are
actively investigating the exact molecular mechanisms through
which the phosphorylation of AFAP-110 leads to podosome
disassembly.
Materials and Methods
Cell culture and reagents
A7r5 rat vascular smooth muscle cells were purchased from the American Type
Culture Collection (ATCC) and grown in low-glucose (1 g/l) Dulbecco’s modified
Eagle’s medium (DMEM; Mediatech) supplemented with 10% fetal bovine serum
(FBS, Atlanta Biologicals), 2 mM L-glutamine (Gibco), and penicillin/streptomycin
(Mediatech) at 37°C with 5% CO2. A7r5 cells were transfected with Lipofectamine
and Plus reagent (Invitrogen) according to the manufacturer’s protocol. The COS-7
cell line was grown in high-glucose (4.5 g/l) DMEM (Mediatech), 10% FBS, 2 mM
L-glutamine and penicillin/streptomycin at 37°C with 5% CO2. For transfection of
COS-7 cells Polyfect (Qiagen) was used according to the manufacturer’s protocol.
The following antibodies were used for western blotting or immunofluorescence:
anti-GFP (Invitrogen), anti-AFAP-110 [first described by Flynn et al. (Flynn et al.,
1993)], anti-cortactin (4F11 from Upstate), tetramethylrhodamine-isothiocyanate
(TRITC)-conjugated phalloidin (Sigma). The antibody specific against phosphorylated
AFAP-110 was generated by 21st Century Biochemicals. Briefly, rabbits were
immunized repeatedly with AFAP-110 peptide (encoding amino acids 273-283)
phosphorylated at Ser277. Antibody reactivity was tested by ELISA and
phosphorylation specificity was initially confirmed in a dot-blot assay. Non-
phosphorylated or phosphorylated peptides were suspended in water and 1 μl of
aliquots of different peptide concentrations (5-1200 ng) were spotted on a
nitrocellulose membrane that was hybridized with rabbit antiserum (1:1000).
Subsequently, the phosphospecific antibody was affinity-purified by affinity absorption
against the phosphorylated peptide by 21st Century Biochemicals.
The PKC inhibitors staurosporine, rottlerin and Safingol as well as the Src-specific
inhibitor PP2 were purchased from EMD Biosciences.
Constructs
The following constructs have been described previously : GFP-AFAP-110 and GFP-
AFAP-110 ΔPH (Qian et al., 2002), GFP-AFAP-110P71A (Guappone and Flynn, 1997),
GFP-AFAP-1101-616 and GFP-AFAP-1101-553 (Qian et al., 2000). To eliminate the
potential Ser phosphorylation sites at positions 277, 278, 282 and 283 the GFP-AFAP-
110 construct was subjected to single or multiple rounds of site-directed mutagenesis
using the Stratagene QuikChange Site-Directed Mutagenesis Kit according to the
manufacturer’s recommendations., resulting in the 4A mutant (S277A-S278A-
S282A-S283A), S277A-S278A and S282A-S283A double mutants, or S277A and
S278 single amino acid mutants. HA-AFAP was generated by PCR amplification and
cloned into pCMV-HA. All constructs were confirmed by sequence analysis. PKCα
expression constructs were a kind gift from Alex Toker (Israel Deaconess Medical
Center, Boston, MA) and have been described previously (Gatesman et al., 2004).
Immunoprecipitation and immunoblotting
For phorbol-12-myristate-13-acetate (PMA, EMD Biosciences) treatment of cells,
PMA was used at 100 nM for 1 hour if not indicated otherwise. In overexpression
experiments cells were directly lysed in equal volumes of Laemmli sample buffer
and equal volumes were used for sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE). For immunopreciptiation of endogenous AFAP-110,
cells were lysed for 20 minutes on ice in RIPA lysis buffer (10 mM Na2PO4 pH
7.2, 150 mM NaCl, 1% NP40, 1% sodium deoxycholate, 0.1% SDS, 2 mM EDTA,
5 μg/ml aprotinin, 2 μg/ml leupeptin, 1 mM PMSF, 100 mM sodium fluoride, 10
mM β-glycerophosphate, 100 μM sodium orthovanadate), sonicated briefly and
cleared by centrifugation at 4°C for 10 minutes at 12,000 g. Protein concentrations
were determined using a BCA Protein Assay Kit (Pierce) according to the
manufacturer’s protocol. Equal protein amounts were used for immunoprecipitation
with 2 μg AFAP-110 antibody overnight at 4°C followed by incubation with protein
A sepharose (Sigma) for 1 hour at 4°C. Immune-complexes were washed twice
with RIPA lysis buffer and once with phosphate-buffered saline (PBS) before SDS
sample buffer was added and SDS-PAGE was performed. Resolved proteins were
transferred by semi-dry electroblotting to a polyvinylidene fluoride (PVDF)
membrane (Immobilon-P from Millipore). Proteins were detected by incubation
with primary antibodies as indicated, in a solution of 5% (w/v) powdered milk,
0.05% (v/v) Tween 20 in TBS, followed by incubation with a 1:3000 dilution of
secondary donkey anti-mouse or donkey anti-rabbit horseradish-peroxidase-
conjugated antibodies (GE Healthcare Bio-Sciences). Peroxidase-conjugated
secondary antibodies were visualized by enhanced chemiluminescence. To re-probe
membranes the antibodies were stripped off the membrane by incubation at 65°C
in SDS-stripping buffer for 30-60 minutes.
Immunofluorescence
Cells were seeded on 10 μg/ml fibronectin-coated coverslips and grown overnight.
Where indicated cells were treated with 1 μM phorbol-12,13-dibutyrate (PDBu; EMD
Biosciences) for 1 hour, then fixed in 3.7% formaldehyde, permeabilized with 0.2%
Triton X-100 and stained for actin with TRITC-phalloidin and polyclonal AFAP-110
antibody. Secondary antibodies (Invitrogen) were used at a 1:200 dilution. Coverslips
were mounted on slides with Fluoromount-G (Southern Biotech) and pictures were
taken with a Zeiss LSM 510 microscope. Images were imported into Photoshop 7.0
(Adobe) for processing.
Matrix-degradation assay
ECM degradation assays were performed as described by Burgstaller and Gimona
(Burgstaller and Gimona, 2005) with modification. A glass coverslip was coated with
poly-L-Lysine and crosslinked with 2.5% glutaraldehyde. Oregon Green 488 gelatin
(Sigma) was mixed with 50 ug/ml fibronectin in 2 M urea buffer in PBS and layed
over the poly-L-lysine-coated coverslip. After quenching with borohydride (5 mg/ml),
the coverslip was washed, sterilized with ethanol, and then equilibrated with complete
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medium. Cells were allowed to degrade the gelatin and fibronectin mixture for 16
hours. Images were obtained from an Axiovert 200M inverted microscope.
Time-lapse analysis of podosomes in A7r5 overexpressing wt
AFAP-110 or AFAP-110S277A
A7R5 were transiently transfected with EGFP-AFAP-110 or EGFP-AFAP-110S277A
mutant using Lipofectamine and PLUS reagent (Invitrogen). After a 24-hour
incubation, the transfected cells were plated on Delta T dishes (Bioptechs Inc) pre-
coated with 50 μg/ml fibronectin and allowed to adhere for 24 hours. Medium was
replaced with DMEM containing 25 mM HEPES without Phenol Red and
supplemented with 10% FBS before each videomicroscopy analysis. Cells with EGFP
AFAP-110-positive podosomes were videotaped at 37°C for up to 3 hours, using a
Nikon Swept-field inverted microscope equipped with a CoolSNAP HQ2 16-bit
camera (Photometrics) or a Zeiss Axiovert 200M inverted microscope. The acquired
images were analyzed with ImageJ (NIH image) with MTrackJ and ParticleTracker
Plugins. Duration, intensity and net speed of each podosome were recorded. When
a podosome underwent fission, the daughter podosome with brighter intensity was
regarded as the continuing podosome and the other daughter podosome as a new
podosome. To obtain the average lifetime of podosomes, only the lifespan of
podosomes that had appeared and had disappeared during videomicroscopy were
used. The two-tailed Student’s t-test with non-equal variance was used to determine
the statistical significance of duration difference between podosomes containing wild
type and 277A mutant of AFAP-110.
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